Results 51 to 60 of about 83,162 (185)

Desarrollo y evaluación de un repositorio para usos secundarios conforme a OMOP-CDM para la cohorte CoRIS [PDF]

, 2021
Cada vez más instituciones de investigación, sanitarias, consorcios científicos, etc., despliegan registros y redes de registros de investigación para el uso secundario de datos, que permiten la incorporación e intercambio automatizado de datos, acceso ...
Moreno-Prieto, Cristina, Burgos Llamo, Alfredo, Pedrera-Jiménez, Miguel, Muñoz Carrero, Adolfo, CoRIS Cohort, Pascual-Carrasco, Mario, Gálvez Fernández, Marta, de Vicente Guijarro, Jorge   +7 more
core   +1 more source

Mapping von openEHR zu FHIR und OMOP CDM zur Unterstützung der Interoperabilität für die Infektionskontrolle

, 2021
Healthcare delivery and health outcomes of patients could significantly improve if the different electronic health systems of medical institutions were interoperable, that is if they could exchange and combine their data in a meaningful way. In addition,
Thun, S, Rinaldi, E
core   +1 more source

Transforming Primary Care Data Into the Observational Medical Outcomes Partnership Common Data Model: Development and Usability Study

JMIR Medical Informatics
BackgroundPatient-monitoring software generates a large amount of data that can be reused for clinical audits and scientific research. The Observational Health Data Sciences and Informatics (OHDSI) consortium developed the Observational Medical Outcomes ...
Mathilde Fruchart, Paul Quindroit, Chloé Jacquemont, Jean-Baptiste Beuscart, Matthieu Calafiore, Antoine Lamer   +5 more
doaj   +1 more source

Automatic Data Transfer from OMOP-CDM to REDCap: A Semantically-Enriched Framework [PDF]

, 2021
n ...
Emanuele Girani, Matteo Gabetta, Anna Alloni, Morena Stuppia, Lucia Sacchi, Nicola Barbarini   +5 more
openaire   +4 more sources

The potential impact of H1 antihistamines on clinical outcomes in NSCLC patients undergoing EGFR‐TKIs treatment

British Journal of Clinical Pharmacology, EarlyView.
Background Epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR‐TKIs) have substantially improved outcomes in non‐small cell lung cancer (NSCLC); however, the development of treatment resistance remains a major clinical challenge. This study examines the association between concomitant prescriptions of H1‐antihistamines (H1AHs) and ...
Van Thuan Nguyen, Ngoc Hoang Le, Nhu Quynh Phan, Toan Trung Duong, Le Thi Anh Thu, Hsuan‐Chia Yang, Chih‐Wei Huang, Min‐Huei Hsu, Jason C. Hsu, Chien‐Tien Su, Phung‐Anh Nguyen   +10 more
wiley   +1 more source

Multimodal artificial intelligence in medical biotechnology: Integrating genomics, imaging, and clinical data for precision therapeutics

Precision Medical Sciences, EarlyView.
Overview of multimodal artificial intelligence (AI) for precision therapeutics. Diverse biomedical data modalities, including multi‐omics, medical imaging, digital pathology, electronic health records, wearable‐device data, and molecular information, are integrated through multimodal AI frameworks incorporating fusion strategies, foundation models ...
Gedion Mengistu Dejen
wiley   +1 more source

Big Data in Cancer Genomics: Computational Foundations and Emerging Pathways for Precision Oncology

Computational and Systems Oncology, Volume 6, Issue 1, December 2026.
ABSTRACT This review aims to explore the computational foundations of big data in cancer genomics and examine emerging pathways that support precision oncology and personalized cancer care. A narrative review approach was adopted to synthesize evidence from PubMed, Scopus, Web of Science, and IEEE Xplore.
Nur Vanu, Nur Mohammad, Fahad Ahmed, Towsif Alam, Koushik Saha, Durga Shahi, Adib Hossain, Mia Md. Tofayel Gonee Manik, Mst. Rina Parvin   +8 more
wiley   +1 more source

Leveraging artificial intelligence and data science techniques in harmonizing, sharing, accessing and analyzing SARS-COV-2/COVID-19 data in Rwanda (LAISDAR Project): study design and rationale

BMC Medical Informatics and Decision Making, 2022
Background Since the outbreak of COVID-19 pandemic in Rwanda, a vast amount of SARS-COV-2/COVID-19-related data have been collected including COVID-19 testing and hospital routine care data.
Aurore Nishimwe, Charles Ruranga, Clarisse Musanabaganwa, Regine Mugeni, Muhammed Semakula, Joseph Nzabanita, Ignace Kabano, Annie Uwimana, Jean N. Utumatwishima, Jean Damascene Kabakambira, Annette Uwineza, Lars Halvorsen, Freija Descamps, Jared Houghtaling, Benjamin Burke, Odile Bahati, Clement Bizimana, Stefan Jansen, Celestin Twizere, Kizito Nkurikiyeyezu, Francine Birungi, Sabin Nsanzimana, Marc Twagirumukiza   +22 more
doaj   +1 more source

Characterizing the Anticancer Treatment Trajectory and Pattern in Patients Receiving Chemotherapy for Cancer Using Harmonized Observational Databases: Retrospective Study

JMIR Medical Informatics, 2021
BackgroundAccurate and rapid clinical decisions based on real-world evidence are essential for patients with cancer. However, the complexity of chemotherapy regimens for cancer impedes retrospective research that uses observational health databases.
Jeon, Hokyun, You, Seng Chan, Kang, Seok Yun, Seo, Seung In, Warner, Jeremy L, Belenkaya, Rimma, Park, Rae Woong   +6 more
doaj   +1 more source

Early and High‐Dose Glucocorticoid Use and Survival in Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Multicenter Target Trial Emulation

Clinical Pharmacology &Therapeutics, Volume 120, Issue 4, Page 1129-1141, October 2026.
Despite the immunomodulatory mechanism of immune checkpoint inhibitors (ICIs), systemic glucocorticoids are commonly used in advanced non–small cell lung cancer (NSCLC). Evidence regarding their effects on ICI outcomes is inconsistent, in part due to confounding by indication and immortal time bias.
Da Eun Lee, Geunho Lim, Minoh Ko, Mari Kim, Ji Sun Chun, Borim Lee, Miso Kim, Kwangsoo Kim, Byung Kwan Choi, Jeongmin Seo, Jin Hyoung Kang, Taehoon Ko, In‐Wha Kim, Jung Mi Oh   +13 more
wiley   +1 more source